Heads

Heads is a full-service global Contract Research Organization (CRO) dedicated to conducting clinical research with expertise in hematology and oncology studies. It provides comprehensive clinical trial services from initiation to completion, covering Phase I to Phase IV trials. Additionally, it offers strategic oncology drug development consulting and expert advice, as the team understands the challenges of developing anticancer drugs in a complex, competitive, and rapidly evolving oncology market.